MOLN:SWX
Molecular Partners AG
CHF 3.05
arrow_downward
-0.33%(-0.0100) 1D
Oct 20, 5:30:05 PM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLN...
Open
CHF 3.08
High
CHF 3.10
Low
CHF 3.04
Mkt. cap
123.14M
Avg. vol.
10.48K
Volume
10.96K
52-wk high
CHF 3.96
52-wk low
CHF 2.66
EPS
-CHF 1.37
Shares outstanding
40.37M
No. of employees
134
Open
CHF 3.08
High
CHF 3.10
Low
CHF 3.04
Mkt. cap
123.14M
Avg. vol.
10.48K
Volume
10.96K
52-wk high
CHF 3.96
52-wk low
CHF 2.66
EPS
-CHF 1.37
Shares outstanding
40.37M
No. of employees
134
News stories
From web sources and news partners
FXStreet
·
50 minutes ago
Dow Jones Industrial Average rises on earnings, cheaper Crude Oil
Investing.com
·
19 minutes ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 1.02%
ChartMill
·
1 hour ago
S&P 500 Top Movers: EFX and HAS Lead Today's Gainers, GM and DVA Fall
Insider Monkey
·
3 hours ago
Ciena (CIEN): Is the AI-Optical Boom Enough to Carry It Into the S&P 500?
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
About Molecular Partners AG